Trial Profile
A Randomized, 2 Part, 4-treatment, 2-way Cross-over Study in Healthy Volunteers to Compare the Pharmacokinetic and Pharmacodynamic Profiles of 1ug/kg of DA-3880 and EU Sourced ARANESP (Amgen) After Single Intravenous or Subcutaneous Administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2021
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary) ; Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 13 Jun 2021 Status changed from recruiting to completed.
- 19 Sep 2014 New trial record